"Designing Growth Strategies is in our DNA"
Upsurge in livestock diseases impose a considerable burden on the economy and agriculture of many countries. Use of livestock vaccines can help in preventing a wide range of disease in animals as well as spread of these diseases to humans. Livestock vaccines, commonly available in live attenuated or inactivated forms, have been utilized successfully in the prevention of diseases in animals and humans. The potential benefits of livestock vaccines include improvement in animal welfare and public health.
Many clinical studies are undertaken to develop vaccines for various livestock disease using new vaccine technologies such as marker vaccine, split –product, isolated protein or peptide and nucleic acid approaches. Furthermore, global livestock vaccines market has paved its way for many key mergers and acquisitions. For example, in 2016, Elanco U.S., Inc., a subsidiary company of Eli Lilly and Company acquired the U.S. canine, feline and rabies animal vaccines portfolio of Boehringer Ingelheim Vetmedica, Inc., one of the major players in animal health.
To gain extensive insights into the market, Request for Customization
The growth in global livestock vaccines market is being driven by the increased demand for recombinant vaccine, DNA vaccines, multivalent vaccines and others. The outbreak of diseases such as the African Swine Fever (ASF), affecting millions of pigs in China, Vietnam, Cambodia, and other south-east Asian countries in 2018, and Mycoplasma bovis infections among cattle in 2018, in New Zealand, is among the major factors propelling the demand for vaccines in the global market. In addition, the increasing government initiatives to prevent the spread of zoonotic diseases is also expected to fuel the growth in global livestock vaccines market during the forecast years.
However, lack of availability of vaccines, and inoperative vaccination centres in emerging countries especially India, China, and Brazil, which hold a dominant proportion of livestock animals, is a major restraining factor in the global livestock vaccines market.
The major companies covered in the global livestock vaccines market report include Merck & Co., Inc., Pfizer Inc., AgriLabs, Zoetis, Novartis AG, Boehringer Ingelheim, Bayer AG, Eli Lilly and Company, Virbac, Neogen Corporation, ImmuCell Corporation and other players.
By Animal Type
By Vaccine Type
By Route of Administration
By Disease Indication
By Distribution Channel
As per the current livestock vaccines market trends, attenuated vaccines among the vaccine type accounted for dominant market share in the global livestock vaccines market owing to benefits such as higher efficiency and long-term prevention.
The global livestock vaccines market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the livestock vaccines market followed by Europe. The livestock vaccines market is anticipated to expand in North America during the forecast years owing to awareness regarding the prevention of animal-to-human transmission of diseases, higher demand for meat, and investment in research and development in animal vaccines. Asia Pacific is anticipated to grow at a significant CAGR during the forecast period due to the rising prevalence of livestock diseases such as foot-and-mouth disease (FMD) and highly pathogenic avian influenza (HPAI). Additionally, the increasing incidence of zoonotic diseases, initiatives by government organisations and animal associations to provide access to livestock vaccines, are expected to fuel growth of the livestock vaccines market in the Asia Pacific region. The livestock vaccines market in Middle East & Africa and Latin America is in the nascent stage; however, it is anticipated to grow at a moderate CAGR during the forecast period.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry